Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen
Clinical trial NCT04013581 · COMPLETED
Trial details
- NCT number
- NCT04013581
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2020-05-13
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.